Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF.
"The acquisition of DESI technology bolsters Waters' portfolio of mass spectrometry imaging innovations, a rapidly expanding MS technique for biomedical research and related applications," said Chris O'Connell, Chairman and Chief Executive Officer, Waters Corporation. "DESI mass spectrometry imaging provides complementary and actionable data when compared to classical histopathology imaging technologies with major advantages in analyzing the molecular fingerprint within a sample, thus delivering deeper biological insights. Ultimately, these insights will lead to better understanding of disease and enable the development of new, more effective medical therapies."
DESI imaging technology uses a charged jet of solvent depositing micro-droplets onto a sample's surface where analytes are desorbed into a gas phase at ambient pressure and temperature. Subsequently, they are drawn in and analyzed by mass spectrometry.
"We at Prosolia are proud of our role in developing and commercializing DESI technology," said Justin Wiseman, Chief Executive Officer, Prosolia. "The potential for MSI analysis using DESI technology is significant because of the quality of the data, the minimal sample preparation required, and the non-destructive nature of the technique allowing for multimodal analysis on a single sample."
In connection with Waters’ acquisition of DESI intellectual property from Prosolia and licensing from PRF, Waters and Purdue University, where DESI was invented by a team led by R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry, have also established a relationship under the terms of a new license agreement. Accordingly, Waters will provide Purdue University with a Synapt™ G2-Si time-of-flight mass spectrometer to continue to advance research applications of DESI technology.
"Today's announcement is an important milestone in the continued growth of DESI to the benefit of scientists around the globe. We congratulate Justin and the Prosolia team for their accomplishments and look forward to collaborating with Waters as it takes DESI into the future," commented Dr. Cooks.
Waters Appoints John M. Ballbach to Board of Directors
Waters Corporation announced the appointment of John M. Ballbach to its Board of Directors, effective October 5, 2021. Mr. Ballbach currently serves on the Board of RPM International, Inc., a leader in specialty coatings, sealants, building materials and related services. Waters also announ ... more
Waters Corporation has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to further explore the use of Waters’ cutting-edge ion mobility spectrometry (IMS) in the investigation of compounds in complex mixtures. Identifying ... more
Waters Corporation Names Udit Batra President and Chief Executive Officer
Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as Pr ... more
LC Analyses without the Unpredictability of Analyte Losses due to Metal Interactions
Less analyte losses due to metal interactions ✓ No time-consuming system- and column passivation ✓ Highest sensitivity, reproducibility and more stability ✓ more
Performance you need, Results you can trust
Ever-evolving regulations are impacting LC method approaches for product quality control and beyond. Count on the Arc HPLC System for high-efficiency separations and quality data to help meet your regulatory requirements with confidence. Arc HPLC allows you to easily replicate and improve t ... more
Did you know that metal interactions can put your analytical results at RISK?
Non-specific adsorption (NSA) of metal sensitive analytes can lead to loss of sensitivity, poor peak shape, poor reproducibility and lengthy passivation procedures. The occurrence of these NSA losses can be hard to predict and therefore, a good plan to mitigate them leads to less risk and ... more
New protein for gene editing may improve disease treatment
Gene editing has been a much sought after and controversial technology. Last month, part of the World Health Organization called for an international registry to track all research into editing the human genome. Purdue University researchers, including one who was inspired by the cancer dea ... more
Cancer identity technology makes it easier to find a tumor's 'address'
Purdue University researchers have developed a technology aimed at making it easier to deliver cancer treatment to the right "address" in the body while also easing the painful side effects of chemotherapy on patients. One of the big issues with chemotherapy is that most treatment approache ... more
New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
Purdue University researchers have developed a new flexible and translucent base for silicon nanoneedle patches to deliver exact doses of biomolecules directly into cells and expand observational opportunities."This means that eight or nine silicon nanoneedles can be injected into a single ... more
Automated System to Detect Cracks in Nuclear Power Plants
A new automated system detects cracks in the steel components of nuclear power plants and has been shown to be more accurate than other automated systems. more
